Drug Profile
Somatropin - Teva/TransPharma Medical
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator TransPharma Medical
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Somatotropin deficiency
Most Recent Events
- 23 Sep 2010 No development reported - Phase-I for Somatotropin deficiency in Israel (Transdermal)